Moexipril
- Generic Name
- Moexipril
- Brand Names
- Univasc
- Drug Type
- Small Molecule
- Chemical Formula
- C27H34N2O7
- CAS Number
- 103775-10-6
- Unique Ingredient Identifier
- WT87C52TJZ
Overview
Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.
Background
Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.
Indication
用于治疗高血压。
Associated Conditions
- Hypertension
Clinical Trials
FDA Approved Products
Univasc
Manufacturer:UCB, Inc.
Route:ORAL
Strength:7.5 mg in 1 1
Approved: 2016/02/23
NDC:0091-3707
Moexipril Hydrochloride
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:7.5 mg in 1 1
Approved: 2011/04/14
NDC:54868-5928
Moexipril Hydrochloride
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:15 mg in 1 1
Approved: 2011/04/14
NDC:54868-4883
Univasc
Manufacturer:UCB, Inc.
Route:ORAL
Strength:15 mg in 1 1
Approved: 2016/02/23
NDC:0091-3715
Moexipril Hydrochloride
Manufacturer:Glenmark Pharmaceuticals Inc., USA
Route:ORAL
Strength:15 mg in 1 1
Approved: 2021/08/18
NDC:68462-208
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath